A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.


Updates from The Motley Fool

Latest updates on Osiris Therapeutics from Fool.com.
This Week in Biotech

With the  SPDR S&P Biotech Index  up 43% over the trailing-12-month period, it's evident that inv...

This Week in Biotech

With the  SPDR S&P Biotech Index  up 34% over the trailing-12-month period, it's evident that inv...

Why Did My Stock Just Die?

Your stock just took a nosedive -- but don't panic. First, let's see whether it had good reason t...

1 Great Stock That Analysts Snub

Small-cap stocks. Herein lies one of your greatest advantages as an individual investor. You have...

Monday's Biggest Stock Stars

Hey there, Fools. I've summoned our Motley Fool CAPS community once again to highlight a few of...



Stock Performance

View Interactive OSIR Charts
Sponsored by

Key Data Points

Primary metrics and data points about Osiris Therapeutics.
Current Price: $5.47
Prev Close: $5.68
Open: $5.67
Bid: $5.34
Ask: $7.08
Day's Range: $5.42 - $5.88
52wk Range: $3.55 - $10.98
Volume: 267,390
Avg Vol 220,386
Market Cap: $188M
P/E (ttm): 113.60
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Osiris Therapeutics.
CAPS Rating 1 out of 5
 
149 Outperform
67 Underperform
CAPS All Stars
 
29 Outperform
27 Underperform

How do you think Osiris Therapeutics will perform against the market?



You pick for Osiris Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Charles Mills, CEO

19% Approve

Based on 5 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Osiris Therapeutics.

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers